New York (www.aktiencheck.de) - Rating-Update:
Patrick Trucchio, Analyst von H.C. Wainwright & Co, stuft die Aktie von Alnylam Pharmaceuticals Inc. (ISIN:…
Boston, MA (www.aktiencheck.de) - Alnylam Pharmaceuticals-Aktienanalysevon Leerink Partners:
Leerink Partners erhöht in einer aktuellen Aktienanalyse das Kursziel für die Aktie von…
San Francisco (www.aktiencheck.de) - Alnylam Pharmaceuticals-Aktienanalyse von Wells Fargo Advisors:
Die Analysten von Wells Fargo Advisors bewerten die Aktie von Alnylam…
New York (www.aktiencheck.de) - Alnylam Pharmaceuticals-Aktienanalyse von der Citigroup:
Die amerikanische Großbank Citigroup stuft die Aktie von Alnylam Pharmaceuticals Inc. (ISIN:…
Toronto (www.aktiencheck.de) - Alnylam Pharmaceuticals-Aktienanalyse von BMO Capital Markets:
Kostas Biliouris, Analyst von BMO Capital Markets, nimmt in einer aktuellen Aktienanalyse…
St. Louis (www.aktiencheck.de) - Alnylam Pharmaceuticals-Aktienanalyse von Stifel:
Stifel rät in einer aktuellen Aktienanalyse zum Kauf der Aktie von Alnylam Pharmaceuticals…
Kulmbach (www.aktiencheck.de) - Alnylam Pharmaceuticals-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Alnylam Pharmaceuticals Inc.…
…
…
MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company,…
The global Antisense and RNAi Therapeutics Market size and share is currently valued at USD 4.34 billion in 2023. It…
…
…
Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) shareholders might be concerned after seeing the share price drop 13% in...…
…
© Reuters Explore Wall Street’s expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon.…
REDWOOD CITY, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Pro Research: Wall Street delves into Alnylam Pharmaceuticals…
NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…
NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an…
NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…
…
…
…
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an…
NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Attention Alnylam Pharmaceuticals, Inc. ("Alnylam") (NASDAQ: ALNY) shareholders:…
NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Attention Alnylam Pharmaceuticals, Inc. ("Alnylam") (NASDAQ: ALNY) shareholders:…
NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an…
AL102 1.2 mg once daily treatment achieved Overall Response Rate of 83% in the evaluable population …
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an…
REHOVOT, Israel & MONMOUTH JUNCTION, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a…
NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an…
…
Alnylam Pharmaceuticals Inc. ALNY said Monday it would no longer pursue its supplemental new drug application (sNDA) for patisiran as…
Major Oligonucleotide API Market players include Ionis Pharmaceuticals, Inc., Jazz Pharmaceuticals plc, Biogen Inc., Sarepta Therapeutics, Alnylam Pharmaceuticals, Inc., Corden…
Alnylam Pharmaceuticals Inc. ALNY said Wednesday its stock will be halted on Nasdaq through the day as a regulatory advisory…
WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals (ALNY) said it plans to appeal a ruling by the U.S. District Court for the…
Greenstreet, Yvonne - Vorstand - Tag der Transaktion: 2023-08-04...…
Poulton, Jeffrey V. - Vorstand - Tag der Transaktion: 2023-08-04...…
Garg, Pushkal - Vorstand - Tag der Transaktion: 2023-08-07...…
Garg, Pushkal - Vorstand - Tag der Transaktion: 2023-08-04...…
Alnylam (ALNY) reports weaker-than-expected second-quarter results. The company also provides updates on its pipeline candidates, which are being developed in…
As per the terms of the exclusive worldwide agreement, Agios will acquire the rights to develop and market Alnylams preclinical…
WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY) revealed Loss for second quarter that decreased from the same period last year…